Navigation Links
Vasogen to Conduct Year-end 2007 Conference Call
Date:1/11/2008

tal on acceptable terms to pursue the development of Celacade, and the feasibility of additional trials. You should not place undue reliance on our forward-looking statements which are subject to a multitude of risks and uncertainties that could cause actual results, future circumstances or events to differ materially from those projected. These risks include, but are not limited to, the outcome of further ongoing analysis of the ACCLAIM trial results, the requirement or election to conduct additional clinical trials and the size and design of any such trials, delays or setbacks in the regulatory approval process, difficulties in the maintenance of existing regulatory approvals, securing and maintaining corporate alliances, the need for additional capital and the effect of capital market conditions and other factors on capital availability, the potential dilutive effects of any financing, risks associated with the outcomes of our preclinical and clinical research and development programs, the adequacy, timing, and results of our clinical trials, competition, market acceptance of our products, the availability of government and insurance reimbursements for our products, the strength of intellectual property, reliance on partners, subcontractors, and key personnel, losses due to fluctuations in the U.S.-Canadian exchange rate, and other risks detailed from time to time in our public disclosure documents or other filings with the Canadian and U.S. securities commissions or other securities regulatory bodies. Additional risks and uncertainties relating to our Company and our business can be found in the "Risk Factors" section of our Annual Information Form and Form 20-F for the year ended November 30, 2006, as well as in our later public filings. The forward-looking statements are made as of the date hereof, and we disclaim any intention and have no obligation or responsibility, except as required by law, to update or revise any forward-looking statements, whether as a
'/>"/>
SOURCE Vasogen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
2. Vasogen Provides an Update on ACCLAIM-II Preparations
3. Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences
4. Vasogen Announces Third Quarter 2007 Results
5. Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
6. Hybrid semiconductors show zero thermal expansion; Could lead to hardier electronics
7. Katie Lee Joel to Conduct Free, Hands-On, Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease
8. NanoMaterials Technology to Conduct Process Development Feasibility Study with US Based Emerging Pharmaceutical Company
9. CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
10. Doping technique brings nanomechanical devices into the semiconductor world
11. IBM and Imago find a crucial difficulty in semiconductor device scaling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Research and Markets has announced the addition ... report to their offering.  http://photos.prnewswire.com/prnh/20130307/600769 ... vitro growth of plant or animal cells for several ... Cell culture is a crucial step in tissue engineering ... consumables are necessary for the in vitro production of ...
(Date:7/24/2014)... , July 24, 2014  CorMedix Inc. (NYSE ... and commercializing therapeutic products for the prevention and ... receipt of notice on July 18, 2014 from ... has accepted the CorMedix plan to regain compliance ... a result, the NYSE-MKT is continuing the Company,s ...
(Date:7/24/2014)... July 24, 2014 WIRB-Copernicus Group ® ... and ethical review services for clinical research, announced ... a division of Richmond, VA ... biosafety and biosecurity consulting firm in ... WCG,s biosafety division – WCG Biosafety™ – will ...
(Date:7/24/2014)... -- Spherix Incorporated (SPEX) -- an intellectual property development company ... today announced that the Company will issue a business ... Monday, August 18, 2014 for shareholders. Management has scheduled ... August 18, 2014 to discuss the company,s progress to ... Anthony Hayes . Following prepared remarks, management ...
Breaking Biology Technology:Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3Spherix Schedules Shareholder Update Call 2
... Yang, Associate Professor of Mechanical Engineering and Director of ... Technology, The Innovation University (TM), will receive funding from ... a Nanoimprint Lithography System (NIL) for the purpose of ... Stevens. The Co-PIs of the project are Drs. Besser, ...
... Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) ... the safety and efficacy of Caldolor® ( ibuprofen ) ... ill adults. Published in the peer-reviewed journal Critical ... significantly more effective at reducing fever in hospitalized patients ...
... Castle Access, Inc. announces the appointment of ... the Castle Access organization with that of its ... provider, and gives clients in Southwestern US and ... data center and mission-critical managed services. ...
Cached Biology Technology:Nanoimprint lithography NSF grant awarded to micro device lab at Stevens 2Nanoimprint lithography NSF grant awarded to micro device lab at Stevens 3Newly Published Caldolor® Clinical Data Demonstrates 77% Reduction in Fever in Hospitalized Patients 2Newly Published Caldolor® Clinical Data Demonstrates 77% Reduction in Fever in Hospitalized Patients 3Newly Published Caldolor® Clinical Data Demonstrates 77% Reduction in Fever in Hospitalized Patients 4Castle Access Names New Managing Director 2Castle Access Names New Managing Director 3
(Date:7/25/2014)... A study published online in the International ... novel approach to preventing cervical cancer based on findings ... after removal of a discrete population of cells in ... study that looked at squamocolumnar junction cells, or SCJ ... have been implicated as the origins of cervical cancer. ...
(Date:7/25/2014)... of Adelaide has opened the way for the development of ... In Australia, annual barley production is second only to wheat ... of the most important diseases of barley. , Senior Research ... of special growths on the cell walls of barley plants ... , The research, by the ARC Centre of Excellence in ...
(Date:7/25/2014)... that the age girls reach puberty is influenced by ,imprinted ... parent contributes the gene. This is the first evidence ... birth and details of this study were published today in ... period, known as menarche, is a marker for the timing ... onset of menses varies between girls, is an inherited trait, ...
Breaking Biology News(10 mins):Clearing cells to prevent cervical cancer 2New hope for powdery mildew resistant barley 2Could age of first period influence development of diseases in older women? 2
... reveals critical molecular events in the origin of fat ... such as obesity and diabetes, as fat cells produce ... The study finds that a hormonal cocktail routinely used ... the transition from fat-cell precursors to full-blown fat, researchers ...
... study reveals critical molecular events in the origin of ... diseases, such as obesity and diabetes, as fat cells ... , The study finds that a hormonal cocktail routinely ... in the transition from fat-cell precursors to full-blown fat, ...
... how a common fish found along the West Coast can ... The study marks the first time that scientists have found ... vertebrate's brain that controls the vocal muscle system and the ... that understanding the auditory system of the plainfin midshipman fish ...
Cached Biology News:Key To Stem Cell Transplant Success Is Tricking Immune System 2Short-term Bio Sensors Monitor From Afar 2How fish hear and make sounds at same time 2
Request Info...
1+ mg expected yield of purified protein, expressed in insect cells - excludes cDNA...
... bioinformatics software that has changed the way ... design of BioNumerics allows for integration and ... data employed for the characterization of organisms ... protein gels, HPLC, VNTR, MLST, SNP, fatty ...
Request Info...
Biology Products: